Merck Settles Fosamax Jaw Decay Lawsuit while Femur Fracture Cases Continue to Mount
Fosamax Litigation Update: Case Management Conference Scheduled for November 2012
- Ennis & Ennis
10/19/2012 - Fosamax femur fracture and Fosamax osteonecrosis of the jaw lawsuits filed in New Jersey Superior Court are scheduled for a Case Management Conference on November 9, 2012 before The Honorable Carol E. Higbee. 
Fosamax was FDA approved in 1995 to treat osteoporosis in postmenopausal women and Paget’s disease of the bone and then later approved for osteopenia, a pre-osteoporosis condition.
Fosamax, with the active ingredient bisphosphonates, is the subjects of hundreds of lawsuits wherein plaintiffs allege that the manufacturer, Merck & Co., failed to warn of the risk of atypical femur fractures (uncommon breaks of the thigh bone) and osteonecrosis of the jaw (death of the jaw bone) caused by drug.
In 2004 studies confirmed a link between Fosamax and osteonecrosis of the jaw, but it wasn’t until July 2005 that Merck changed the label to warn of the ONJ risk.
Prior studies also revealed a link between the use of Fosamax and atypical femur fractures. In fact, in 2008, the U.S. Food and Drug Administration (FDA) issued a warning to consumers and health professionals regarding the atypical femur fracture risk, but it wasn’t until 2010, that Merck finally added the warning of atypical femur fracture risks.
In September 2011 an FDA advisory panel met to discuss the risks associated with Fosamax and reported that studies revealed that there wasn’t any benefit in taking the medication beyond three to five years. This sparked such concern that some physicians are recommending to their patients to stop taking Fosamax after a period of three to five years.
Ennis & Ennis, P.A. has been investigating Fosamax claims since 2004 and continues to offer free, nationwide confidential consultations to patients who have suffered a femur fracture or been diagnosed with osteonecrosis of the jaw while or shortly after taking Fosamax. Contact the lawyers of Ennis & Ennis, P.A. today by calling toll free 1-800-856-6405 or by completing the online case evaluation form on this page.
Ennis & Ennis, P.A. is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington D.C. that concentrates its practice in mass torts and represents individuals against pharmaceutical companies, as well as medical device makers.
Ennis & Ennis, P.A. has been representing clients individually since 1986 and has recovered over $100 million in settlements for its clients.
More Fosamax Side Effects Lawsuit News::
Fosamax Side Effects Lawsuit
If you or a loved one have taken Fosamax and have been injured as a result of Fosamax side effects such as osteonecrosis of the jaw or low energy femur fracture, contact the Fosamax lawyer of Ennis & Ennis, P.A. today. The attorneys of Ennis & Ennis specialize in Fosamax lawsuits. Call us today toll-free: 1-800-856-6405 or fill out our free online case evaluation form.
Under no circumstances should you discontinue taking any medication, including Fosamax, without first consulting with your doctor.